<!doctype html><html><head><meta charset=utf-8><title>More than half of the FDA entire budget now comes from Big Pharma, not the govt.</title>
<link rel=stylesheet href="/css/main.css?v=1753303881"><link rel=stylesheet href="/css/pagination.css?v=1753303881"><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css><script src="/js/search-suggestions.js?v=1753303881"></script><script src="/js/search.js?v=1753303881"></script><script type=module>
        
        window.initPagefind = async function() {
            try {
                console.log('Loading Pagefind module...');
                window.pagefind = await import('/pagefind/pagefind.js');
                if (!window.pagefind) {
                    throw new Error('Failed to load Pagefind module - import returned empty result');
                }
                
                console.log('Initializing Pagefind...');
                const initResult = await window.pagefind.init();
                console.log('Pagefind loaded and initialized');
                
                
                if (window.searchInstance) {
                    console.log('Notifying Search instance of Pagefind initialization');
                    window.searchInstance.initializePagefind(window.pagefind);
                    console.log('Search instance successfully notified');
                } else {
                    console.warn('Search instance not found in global scope yet, but Pagefind is loaded');
                    
                }
            } catch (error) {
                console.error('CRITICAL ERROR: Failed to initialize Pagefind:', error);
                
                const errorDetails = error.stack || error.message || String(error);
                console.error('Error details:', errorDetails);
                
                
                const statusEl = document.querySelector('#search-status');
                const inputEl = document.querySelector('#search-input');
                
                if (statusEl) {
                    statusEl.textContent = 'Search unavailable: ' + error.message;
                    statusEl.style.display = 'block';
                    statusEl.style.color = 'red';
                }
                
                if (inputEl) {
                    inputEl.disabled = true;
                    inputEl.placeholder = 'Search unavailable';
                }
            }
        };
        
        
        window.pagefindInitialized = false;
        
        
        document.addEventListener('DOMContentLoaded', () => {
            console.log('DOM loaded, initializing Pagefind...');
            window.initPagefind();
        });
    </script></head><body><div class=top-nav><div class=home-icon><a href=/ title="Go to Home Page"><svg viewBox="0 0 576 512" width="28" height="28"><path d="M575.8 255.5c0 18-15 32.1-32 32.1h-32l.7 160.2c0 2.7-.2 5.4-.5 8.1V472c0 22.1-17.9 40-40 40H456c-1.1.0-2.2.0-3.3-.1-1.4.1-2.8.1-4.2.1H416 392c-22.1.0-40-17.9-40-40V448 384c0-17.7-14.3-32-32-32H256c-17.7.0-32 14.3-32 32v64 24c0 22.1-17.9 40-40 40H160 128.1c-1.5.0-3-.1-4.5-.2-1.2.1-2.4.2-3.6.2H104c-22.1.0-40-17.9-40-40V360c0-.9.0-1.9.1-2.8V287.6H32c-18 0-32-14-32-32.1.0-9 3-17 10-24L266.4 8c7-7 15-8 22-8s15 2 21 7L564.8 231.5c8 7 12 15 11 24z"/></svg></a></div><div class=search-container><div class=search-icon><i class="fas fa-search"></i></div><input type=text id=search-input placeholder=Search... disabled><div id=suggestions class=search-suggestions style=display:none></div><ul id=search-results style=display:none></ul><div id=search-results-panel class=search-results-panel><div class=results-header>Search Results</div><ul id=search-results-panel-list class=results-list></ul></div></div></div><div class=container><div class="content content-full-width" role=main><article><div class=scroll-nav-top><a href=javascript:void(0); id=scroll-to-bottom class=scroll-button aria-label="Scroll to bottom" onclick='return window.scrollTo({top:document.body.scrollHeight,behavior:"smooth"}),!1'><svg width="16" height="16" fill="currentcolor" viewBox="0 0 16 16"><path d="M8 4a.5.5.0 01.5.5v5.793l2.146-2.147a.5.5.0 01.708.708l-3 3a.5.5.0 01-.708.0l-3-3a.5.5.0 11.708-.708L7.5 10.293V4.5A.5.5.0 018 4z"/></svg>
<span>Scroll to Bottom</span></a></div><h1>More than half of the FDA entire budget now comes from Big Pharma, not the govt.</h1><time>September 28, 2018</time><div data-pagefind-body><h4 id=drug-companies-pay-fda-and-nih-pays-universities-to-fast-track-and-market-vaccineshttpsarticlesmercolacomsitesarticlesarchive20180928fast-track-approvals-of-new-vaccinesaspxutm_sourcednlutm_mediumemailutm_contentart1utm_campaign20180928z1_ucmet_ciddm236053et_rid43116259020-mercola-sept-2018><a href="https://articles.mercola.com/sites/articles/archive/2018/09/28/fast-track-approvals-of-new-vaccines.aspx?utm_source=dnl&amp;utm_medium=email&amp;utm_content=art1&amp;utm_campaign=20180928Z1_UCM&amp;et_cid=DM236053&amp;et_rid=431162590%20">Drug Companies Pay FDA and NIH Pays Universities to Fast Track and Market Vaccines</a> Mercola Sept 2018</h4><ul><li><p>“In 1992, Congress passed the Prescription Drug User Fee Act (PDUFA) to accelerate FDA licensing approvals of new drugs and vaccines. More than half of the FDA’s budget is now funded by the pharmaceutical industry through PDUFA fees” <a href=https://www.businessinsider.com/fda-user-fees-from-pharmaceutical-companies-2016-8>Reference</a></p></li><li><p>“This raises serious questions about the integrity of the FDA licensing process when Congress has allowed drug companies to, in effect, bribe the FDA to lower licensing standards in order to grease the skids for certain drugs and vaccines to be fast-tracked to licensure”</p></li></ul><p>50 references on the Mercola webpage</p><hr><h4 id=the-biopharmaceutical-industry-provides-75-of-the-fdas-drug-review-budget-is-this-a-problemhttpswwwforbescomsitesjohnlamattina20180628the-biopharmaceutical-industry-provides-75-of-the-fdas-drug-review-budget-is-this-a-problem35b3eacd49ec-forbes-june-2018><a href=https://www.forbes.com/sites/johnlamattina/2018/06/28/the-biopharmaceutical-industry-provides-75-of-the-fdas-drug-review-budget-is-this-a-problem/#35b3eacd49ec>The Biopharmaceutical Industry Provides 75% Of The FDA&rsquo;s Drug Review Budget. Is This A Problem?</a> Forbes June 2018</h4><hr><h4 id=fda-repays-industry-by-rushing-risky-drugs-to-markethttpswwwpropublicaorgarticlefda-repays-industry-by-rushing-risky-drugs-to-market-propublica--june-2018><a href=https://www.propublica.org/article/fda-repays-industry-by-rushing-risky-drugs-to-market>FDA Repays Industry by Rushing Risky Drugs to Market</a> ProPublica June 2018</h4><ul><li>&ldquo;Faster reviews mean that the FDA often approves drugs despite limited information. It channels more and more experimental treatments, including Nuplazid, into expedited reviews that <strong>require only one clinical trial to show a benefit to patients</strong> , instead of the traditional two.&rdquo;</li></ul><hr><h4 id=additional-references-for-a-single-trial-being-enough---which-started-in-1998>Additional references for a single trial being enough - which started in 1998</h4><ol><li><strong>CLINICAL TRIAL EVIDENCE SUPPORTING FDA APPROVAL OF NOVEL THERAPEUTICS, 2005–2012</strong> - 2014</li></ol><blockquote><p><i class="fas fa-file-pdf" style=margin-right:.3em></i><a href=https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/clinical-trial-evidence.pdf>Download the PDF from VitaminDWiki</a>__</p></blockquote><blockquote><img src=https://d378j1rmrlek7x.cloudfront.net/attachments/jpeg/clinical-trials.jpg alt=image width=400></blockquote><blockquote></blockquote><ol><li><strong>Substantial Evidence: When Is a Single Trial Sufficient for Approval and Promotion?</strong> 2011</li></ol><blockquote><p><i class="fas fa-file-pdf" style=margin-right:.3em></i><a href=https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/substantial-evidence-when-is-a-single-trial-suffic.pdf>Download the PDF from VitaminDWiki</a></p></blockquote><blockquote><p>Since 1998 a single trial is enough in various cases (details in PDF)</p></blockquote><blockquote><p>Case 1: substantial evidence proven via extrapolation from existing studies or from new comparative PK bioavailability trial. No new AWCT required</p></blockquote><blockquote><p>Case 2: a single AWCT with independent substantiation from related clinical data</p></blockquote><blockquote><p>Case 3: reliance on a single multicenter study, without supporting information. Single AWCT</p></blockquote><ol><li><strong>Guidance for Industry FDA - 1998</strong></li></ol><blockquote><p><i class="fas fa-file-pdf" style=margin-right:.3em></i><a href=https://d378j1rmrlek7x.cloudfront.net/attachments/pdf/guidance-for-industry-fda-1998.pdf>Download the PDF from VitaminDWiki</a></p></blockquote><ol><li><strong><a href=http://www.center4research.org/fda-expedited-approval-process-raises-concerns-risks/>FDA Expedited Approval Process Raises Concerns About Risks</a></strong> July 2018</li></ol><blockquote><p>&ldquo;In addition, over half of the approvals were based on the results of a single trial.&rdquo;</p></blockquote><blockquote><p>&ldquo;It is not known whether the effect observed in the single small trial will be observed in a larger population or replicated in another trial, or whether the effect observed over the short term will persist over the longer term&rdquo;</p></blockquote><blockquote><p>&ldquo;many new cancer drugs approved on the basis of surrogate endpoints retain their approval status and remain available to prescribing physicians even though postmarketing studies show no survival or quality-of-life (QoL) benefit compared with placebo or observation groups.&rdquo;</p></blockquote><blockquote><p>&ldquo;Of 36 drugs that were approved between 2008 and 2012,</p></blockquote><ul><li><p>18 did not significantly prolong overall survival in postmarket studies.</p></li><li><p>QoL information was available for 7 drugs, and</p></li><li><p>Compared with placebo or observation groups,</p><ul><li><p>2 drugs demonstrated worse effects on QoL,</p></li><li><p>4 drugs showed no statistical difference, and</p></li><li><p>1 drug had mixed results. In addition,</p></li><li><p>1 drug reduced overall survival and</p></li><li><p>6 offered no survival benefit compared with placebo or observation groups.&rdquo;</p></li></ul></li></ul><p><strong><span style=color:#00f>Note: Vitamin D trials have found scores of health problems with excellent real-world efficacy including improved Quality of life</span></strong></p><h4 id=note>Note:</h4><ol><li><p><strong>It is unlikely that any group has the $2.4 million to pay the FDA to consider Vitamin D for anything</strong></p></li><li><p><strong>It is unlikely that the FDA would approve it anyway, as doing so could significantly decrease their income</strong></p></li></ol><blockquote><p><strong><span style=color:#00f>&ldquo;It is difficult to get a man to understand something when his salary is dependent upon his not understanding it”</span></strong>  Upton Sinclair</p></blockquote><hr><h4 id=not-a-single-trial-is-needed-for-fda-approval-in-some-cases>Not a single trial is needed for FDA approval in some cases</h4><ol><li><strong><a href=https://www.fdli.org/2018/08/update-fdas-historical-use-of-real-world-evidence/>FDA’s Historical Use of “Real World Evidence”</a></strong> - 2017?</li></ol><ul><li>&ldquo;In June 2017, FDA approved a new indication for a medical device without requiring any new clinical trials.&rdquo;</li></ul></div><hr class=tag-separator><div class=tags><span>Tags: </span><a href=/tags/cancer.html><span class=tag>cancer</span></a>
<a href=/tags/off-topic.html><span class=tag>Off Topic</span></a>
<a href=/tags/top-news.html><span class=tag>Top news</span></a>
<a href=/tags/vitamin-d.html><span class=tag>vitamin d</span></a></div><div data-pagefind-meta=tags hidden>cancer, Off Topic, Top news, vitamin d</div><div class=scroll-nav-bottom id=article-bottom><a href=javascript:void(0); id=scroll-to-top class=scroll-button aria-label="Scroll to top" onclick='return window.scrollTo({top:0,behavior:"smooth"}),!1'><svg width="16" height="16" fill="currentcolor" viewBox="0 0 16 16"><path d="M8 12a.5.5.0 00.5-.5V5.707l2.146 2.147a.5.5.0 00.708-.708l-3-3a.5.5.0 00-.708.0l-3 3a.5.5.0 10.708.708L7.5 5.707V11.5a.5.5.0 00.5.5z"/></svg>
<span>Back to Top</span></a></div></article></div></div><script src="/js/toc-sanitizer.js?v=1753303881"></script><script src="/js/tiki-redirects.js?v=1753303881"></script><script src="/js/lightspa.js?v=1753303881"></script><script>const spa=new LightSPA({mainContentSelector:'[role="main"]',navigationSelector:"[data-spa-nav]"});window.search=new Search({documentsUrl:"/search/search_documents.json.gz?v=1753303881",indexUrl:"/search/search_index.json.gz?v=1753303881"}),document.addEventListener("DOMContentLoaded",function(){function e(e){var t=e.querySelector(".category-expander"),n=e.querySelector(".subcategory-list");e.classList.contains("collapsed")?(e.classList.remove("collapsed"),e.classList.add("expanded"),t.textContent="-",n.style.display="block"):(e.classList.remove("expanded"),e.classList.add("collapsed"),t.textContent="+",n.style.display="none")}document.querySelectorAll(".category-expander").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})}),document.querySelectorAll(".category-name").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})})})</script><script src="/js/scroll-buttons.js?v=1753303881"></script></body></html>